- Home
- ALDX vs LEGT Comparison
ALDX vs LEGT Comparison
Compare ALDX & LEGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- LEGT
- Stock Information
- Founded
- ALDX 2004
- LEGT 2023
- Country
- ALDX United States
- LEGT United States
- Employees
- ALDX N/A
- LEGT N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- LEGT
- Sector
- ALDX Health Care
- LEGT
- Exchange
- ALDX Nasdaq
- LEGT Nasdaq
- Market Cap
- ALDX 313.4M
- LEGT 277.1M
- IPO Year
- ALDX 2014
- LEGT 2024
- Fundamental
- Price
- ALDX $5.26
- LEGT $10.88
- Analyst Decision
- ALDX Strong Buy
- LEGT
- Analyst Count
- ALDX 2
- LEGT 0
- Target Price
- ALDX $9.50
- LEGT N/A
- AVG Volume (30 Days)
- ALDX 647.5K
- LEGT 3.8K
- Earning Date
- ALDX 11-06-2025
- LEGT 01-01-0001
- Dividend Yield
- ALDX N/A
- LEGT N/A
- EPS Growth
- ALDX N/A
- LEGT N/A
- EPS
- ALDX N/A
- LEGT 0.33
- Revenue
- ALDX N/A
- LEGT N/A
- Revenue This Year
- ALDX N/A
- LEGT N/A
- Revenue Next Year
- ALDX $36.23
- LEGT N/A
- P/E Ratio
- ALDX N/A
- LEGT $33.09
- Revenue Growth
- ALDX N/A
- LEGT N/A
- 52 Week Low
- ALDX $1.14
- LEGT $10.20
- 52 Week High
- ALDX $7.20
- LEGT $10.95
- Technical
- Relative Strength Index (RSI)
- ALDX 48.59
- LEGT 66.26
- Support Level
- ALDX $5.13
- LEGT $10.79
- Resistance Level
- ALDX $5.79
- LEGT $10.95
- Average True Range (ATR)
- ALDX 0.28
- LEGT 0.03
- MACD
- ALDX -0.00
- LEGT 0.01
- Stochastic Oscillator
- ALDX 29.10
- LEGT 66.67
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About LEGT Legato Merger Corp. III
Legato Merger Corp III is a blank check company.